Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. serves customers who are accelerating life sciences research, solving complex analytica... read more Featured Products: More products

Download Mobile App




Enhanced Cuvette-Free UV-Visible Spectrophotometer Now Available

By LabMedica International staff writers
Posted on 20 Oct 2015
The next generation of cuvette-free UV-visible spectrophotometers is now available for biotech and other life science laboratories.

The Thermo Fisher Scientific (Milford, MA, USA) NanoDrop One is the next generation instrument in the NanoDrop series of microvolume UV-visible spectrophotometers and will replace the NanoDrop2000 and 2000C instruments. More...


NanoDrop spectrophotometers utilize a patented microvolume sample retention system to minimize sample consumption and eliminate the need for cuvettes. A variable, auto-range pathlength feature allows users to measure up to 366 times higher sample concentrations than can be measured in a 10 millimeter cuvette making dilution steps unnecessary. The NanoDrop One does everything that its predecessors can and more, including: on-board instrument control via a touch screen display, a broader dynamic range, expanded connectivity and data management options, and enhanced sample analysis and technical support with Acclaro Sample Intelligence.

Acclaro Sample Intelligence technology enhances user understanding of sample quality while delivering accurate quantitative measurements. There are three parts to Acclaro: (i) data analysis algorithms that provide contaminant identification and corrected concentrations, (ii) an embedded sensor and digital image analysis that monitors the sample column for bubbles to ensure measurement integrity and (iii) sample information alerts and on-demand technical support for guided troubleshooting.

The NanoDrop One instrument boasts Auto-Measure functionality, while advances in communication technology enable results to be shared and archived via Wi-Fi, Ethernet or USB.

“Building on the success of previous NanoDrop instruments, used by thousands of scientists worldwide, we have designed the NanoDrop One instrument to provide simplicity and speed as well as information on sample quality. This allows scientists to accurately quantify and qualify nucleic acid and protein samples, so they can make informed decisions on sample use in downstream applications,” said Dr. Voula Kodoyianni, product manager, molecular spectroscopy at Thermo Fisher Scientific.

Related Links:

Thermo Fisher Scientific 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Prefilled Tubes
Prefilled 5.0ml Tubes
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.